Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002383984 | SCV002689693 | uncertain significance | Cardiovascular phenotype | 2020-06-16 | criteria provided, single submitter | clinical testing | The p.D4390H variant (also known as c.13168G>C), located in coding exon 29 of the APOB gene, results from a G to C substitution at nucleotide position 13168. The aspartic acid at codon 4390 is replaced by histidine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV004721403 | SCV005327789 | uncertain significance | not provided | 2023-07-31 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as D4363H |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508961 | SCV000605942 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |